RGEN

REPLIGEN CORP

Healthcare | Mid Cap

$0.44

EPS Forecast

$193.7

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncTECHBio-techne CorpCRSPCrispr Therapeutics AgMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc